- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07665216
Chatbot Intervention Effects on Resting-State Brain Function in Anhedonia
June 22, 2026 updated by: Benjamin Becker, University of Electronic Science and Technology of China
Effects of a Chatbot-Based Intervention on Resting-State Functional Connectivity and Spontaneous Neural Activity in Individuals With Anhedonia
The main aim of the present study is to investigate the effects of a Motivational Interviewing-based artificial intelligence chatbot on resting-state brain function in college students with elevated anhedonia and depressive symptoms.
The study will use a randomized active-control intervention design with pre- and post-intervention resting-state functional magnetic resonance imaging assessments.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
Anhedonia represents a core characteristic of depression and is characterized by reduced experience of pleasure.
It is closely related to decreased motivation, altered reward processing, and alterations in intrinsic brain network function.
Resting-state fMRI provides a way to examine intrinsic brain activity and functional connectivity without requiring participants to perform a specific task.
This is important because changes associated with anhedonia may not only appear during reward-related tasks, but may also be reflected in spontaneous brain network organization.
Study Type
Interventional
Enrollment (Estimated)
80
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Benjamin Becker
- Phone Number: (852) 3917-5097
- Email: bbecker@hku.hk
Study Locations
-
-
Sichuan
-
Chengdu, Sichuan, China
- Recruiting
- University of Electronic Science and Technology of China
-
Contact:
- Benjamin Becker, Dr
- Phone Number: (852) 3917-5097
- Email: bbecker@hku.hk
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- 18-40 years
- Right-handed
- Normal or corrected normal visual acuity
- Participants must show elevated anhedonia and depressive symptoms at screening, defined as a total score of 23.5 or higher on the Snaith-Hamilton Pleasure Scale and a score of 14 or higher on the Beck Depression Inventory
Exclusion Criteria:
- History of major central nervous system disorders, such as epilepsy, traumatic brain injury, stroke, or brain tumors.
- History of severe mental illness, including schizophrenia spectrum disorders, bipolar disorder, or other psychotic disorders.
- History of substance or alcohol use disorder or substance or alcohol misuse within the past 12 months that may affect study participation or outcome assessment.
- Individuals currently at high risk of suicide, severe self-harm, or experiencing an acute psychiatric crisis.
- Individuals who are currently using psychiatric medications or have undergone psychotherapy within the past 4 weeks that may significantly affect mood, motivation, or reward processing.
- Severe vision or hearing impairments that cannot be corrected and would interfere with task performance.
- Contraindications to MRI scanning, including metallic implants, pacemakers, severe claustrophobia, or other conditions incompatible with MRI.
- Pregnancy or breastfeeding.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Motivational Interviewing-based AI chatbot group
Motivational Interviewing-based AI chatbot intervention
|
The experimental chatbot is designed to use principles of Motivational Interviewing to support participants in exploring their personal values, motivation for change, and daily behavioral goals related to pleasure, engagement, and reward-seeking.
During the intervention period, participants will interact with the chatbot regularly through brief text-based conversations.
The chatbot will provide empathic, non-judgmental responses, encourage reflection on current difficulties, and help participants identify small, feasible actions that may increase daily engagement and positive experiences.
It will not provide diagnosis, crisis counseling, or medical treatment.
|
|
Active Comparator: Active control chatbot group
Active control nature-story chatbot intervention
|
Participants will interact with a chatbot matched in format and frequency of use.
This chatbot will provide neutral nature-related stories or general natural history content.
It will be designed to maintain participant engagement while avoiding therapeutic techniques, motivational interviewing strategies, behavioral activation guidance, or personalized mental health advice.
This active control condition will help control for nonspecific effects of chatbot interaction, attention, expectancy, and digital engagement.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Intervention-Related Changes in Resting-State Functional Connectivity After the Intervention
Time Frame: Baseline before the first chatbot interaction and Week 1 after completion of the chatbot intervention.
|
Resting-state fMRI will be used to examine functional connectivity among predefined regions involved in reward, social, and self-referential processing.
Connectivity will be estimated from Pearson correlations between regional BOLD time series and then converted using the Fisher z transformation.
Changes from baseline to post-intervention will be reported as dimensionless Fisher z values.
|
Baseline before the first chatbot interaction and Week 1 after completion of the chatbot intervention.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Intervention-Related Changes in Spontaneous Activity After the Intervention
Time Frame: Baseline before the first chatbot interaction and Week 1 after completion of the chatbot intervention.
|
Indices of spontaneous neural activity in regions involved in motivation, social and self-referential processing, will be extracted from resting-state fMRI scans collected at the two assessment points.
These indices will include amplitude of low-frequency fluctuations or fractional amplitude of low-frequency fluctuations, as well as regional homogeneity.
Baseline and post-intervention values will then be compared to characterize pre-to-post changes.
|
Baseline before the first chatbot interaction and Week 1 after completion of the chatbot intervention.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
June 20, 2026
Primary Completion (Estimated)
June 30, 2028
Study Completion (Estimated)
December 31, 2028
Study Registration Dates
First Submitted
June 17, 2026
First Submitted That Met QC Criteria
June 22, 2026
First Posted (Actual)
June 24, 2026
Study Record Updates
Last Update Posted (Actual)
June 24, 2026
Last Update Submitted That Met QC Criteria
June 22, 2026
Last Verified
June 1, 2026
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- BAM_lab_MI_01
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
Corresponding individual level data will be made available upon request.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy
-
University of Vermont Medical CenterAvocado Nutrition CenterRecruitingHealthy | Healthy Volunteers | Healthy Subjects | Healthy Volunteer | Healthy Adult | Healthy Volunteers Only | Healthy Male and Female Subjects | Healthy Non-smokersUnited States
-
Dragonfly TherapeuticsRecruitingHealthy | Healthy Participants | Healthy Adult Females | Volunteer | Healthy Adult MaleAustralia
-
University of PalermoCompletedHealthy | Healthy Volunteers | Healthy Subjects | Healthy Participants | Static Stretching | Stretch | StretchingItaly
-
Prevent Age Resort "Pervaya Liniya"RecruitingHealthy Aging | Healthy Diet | Healthy LifestyleRussian Federation
-
Umm Al-Qura UniversityActive, not recruitingHealthy | Healthy Participants | Healthy Adult | Healthy Women | Healthy Adult Females | Healthy Adult Participants | Healthy Young Adults | Healthy Adult Female Participants | Healthy Adult Male | Poor Sleep Quality | Healthy (Controls) | Poor Sleeping Quality | Healthy Adult Male Subjects | Health Adult SubjectsSaudi Arabia
-
Maastricht University Medical CenterCompletedHealthy Volunteers | Healthy Subjects | Healthy AdultsNetherlands
-
University of PalermoCompletedHealthy Participants | Healthy Adult Participants | Healthy Young AdultsItaly
-
Yale UniversityNot yet recruitingHealth-related Benefits of Introducing Table Olives Into the Diet of Young Adults: Olives For HealthHealthy Diet | Healthy Lifestyle | Healthy Nutrition | CholesterolUnited States
-
PfizerRecruitingHealthy | Healthy AdultsUnited States
-
Atisama TherapeuticsRecruitingHealthy | Healthy SmokerAustralia
Clinical Trials on MI Chatbot Interaction
-
University of Electronic Science and Technology...Recruiting
-
University of Electronic Science and Technology...Recruiting
-
University of Electronic Science and Technology...Recruiting
-
Georgia Institute of TechnologyNational Institute of Neurological Disorders and Stroke (NINDS)Completed
-
The University of Hong KongRecruitingDrug Abuse | Adolescent BehaviorHong Kong
-
Yonsei UniversityBlueSignum CorporationRecruitingAlcohol Drinking | High-Risk Drinking PatternsSouth Korea
-
Distrito Sanitario AlmeriaJunta de AndaluciaCompletedDigital Health | Workplace Violence | Health Professionals | ChatbotSpain
-
University of MinnesotaNational Institute on Minority Health and Health Disparities (NIMHD)Recruiting
-
Corey LesterNational Library of Medicine (NLM)CompletedMachine Intelligence in the PharmacyUnited States
-
University of UtahHuntsman Cancer InstituteNot yet recruitingCancer | Financial ToxicityUnited States